Asimov
Boston, United States· Est. 2017
Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.
Private Company
Total funding raised: $209.7M
About
Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.
Synthetic BiologyAI / Machine LearningBiologics
Funding History
3Total raised:$209.7M
Series B$200MOct 15, 2021
Series A$5MOct 15, 2019
Seed$4.7MMay 15, 2018